We partner with leading institutions in infectious disease research to deliver world-class science.
Drug discovery inspired by African natural products
We are setting up an AI platform for the identification of novel antivirals from African medicinal plants at the University of Buea.
Novel antimalarial and antituberculosis treatments at H3D
AI models can support the decision-making process at every stage of the drug discovery cascade.
Ultra-large scale screening for novel antibiotics
We have partnered with GARDP to identify novel treatments for drug resistant gram-negative infections.
Pharmacogenetics in Africa
Together with H3D, we develop AI pipelines to prioritize genes that potentially affect drug response in African populations.
Open source antimalarials
We have contributed to the Open Source Malaria Consortium, aimed at developing antimalarial drugs following a collaborative approach.
Capacity building
We believe the best way to transfer skills is by working side-by-side with our collaborators. Based on these interactions, we create resources focused on the dissemination of computational skills (AI/ML and others) to scientists in different fields.
